Clinical Trials Directory

Trials / Unknown

UnknownNCT01564979

Effect on Tear Functions of Pretarsal and Preseptal Techniques of Botulinum Toxin Type A Injection in Hemifacial Spasm

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
26 (estimated)
Sponsor
Khon Kaen University · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether pretarsal and preseptal techniques of Botulinum toxin type A injection have any effect on tear functions.

Detailed description

Botulinum toxin type A has been used for hemifacial spasm since 1986. of Botulinum toxin type A can be subcutaneously injected at pretarsal or preseptal portion of orbicularis muscle. Blepharoptosis has been reported less frequently with pretarsal technique, however dry eye was noticed in one patient treated with pretarsal botulinum toxin type A for cosmetic purpose.

Conditions

Interventions

TypeNameDescription
DRUGpreseptal injection of botulinum toxin type Abotulinum toxin type A (Botox)2.5 units, 5 points
DRUGpretarsal injection of Botulinum toxin type ABotulinum toxin type A 2,5 units, 5 points

Timeline

Start date
2012-04-01
Primary completion
2012-09-01
Completion
2012-12-01
First posted
2012-03-28
Last updated
2012-03-28

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01564979. Inclusion in this directory is not an endorsement.